Winton Group LTD Deciphera Pharmaceuticals, Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$7.7 - $37.13 $76,330 - $368,069	-9,913 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$26.46 - $37.15 $262,297 - $368,267	9,913 New	9,913 $337,000
Q4 2020 Feb 12, 2021	SELL	$51.77 - $66.18 $703,036 - $898,724	-13,580 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$43.8 - $58.16 $780,603 - $1.04 Million	-17,822 Reduced 56.75%	13,580 $697,000
Q2 2020 Aug 05, 2020	BUY	$37.05 - $65.03 $586,909 - $1.03 Million	15,841 Added 101.8%	31,402 $1.88 Million
Q1 2020 May 11, 2020	SELL	$33.63 - $69.4 $102,773 - $212,086	-3,056 Reduced 16.42%	15,561 $641,000
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $590,158 - $1.3 Million	18,617 New	18,617 $1.16 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.